| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.1M | +101.8% | — |
| Cost of Revenue | $3.5M | +275.6% | — |
| Gross Profit | $3.6M | +39.8% | — |
| R&D Expense | $15.6M | -18.1% | -36.1% |
| SG&A Expense | $6.7M | +2.1% | -31.9% |
| Operating Income | -$18.6M | +18.9% | +45.5% |
| Pre-tax Income | -$21.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.3M | +200.0% | -47.1% |
| Accounts Receivable | $3.4M | +12.1% | — |
| Inventory | $3.7M | +3108.8% | +1043.1% |
| Current Assets | $230.4M | -5.2% | -21.0% |
| Total Assets | $288.8M | -0.6% | -17.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.0M | — | — |
| Capital Expenditures | $2.1M | — | — |
| Investing Cash Flow | -$43.7M | — | — |
| Financing Cash Flow | -$2.0M | — | — |
| Free Cash Flow | -$50.1M | — | — |
| +30.0% |
| Income Tax | -$108K | -116.2% | -178.3% |
| Net Income | -$20.9M | +7.6% | +30.7% |
| EPS (Basic) | -$0.06 | +14.3% | +33.3% |
| EPS (Diluted) | -$0.06 | +14.3% | +33.3% |
| $28.0M |
| +43.6% |
| +46.4% |
| Total Liabilities | $60.6M | +46.9% | +49.1% |
| Stockholders' Equity | $228.2M | -8.4% | -26.2% |